Exploratory/Developmental Bioengineering Research Grants (EBRG)
Funds early-stage bioengineering projects that test whether a new tool or method could improve cancer research, diagnosis or care.
A new assay, sensor or device idea usually needs proof it can work at all before anyone commits to building it properly. This is the National Cancer Institute's door for that first proof.
The engineering-oriented notice funds exploratory and developmental Bioengineering Research Grant applications that demonstrate feasibility and the potential utility of a new capability, or an improvement in qua…
Exploratory and developmental bioengineering projects demonstrating feasibility and potential utility of a new capability, or an improvement in quality, speed, efficacy, operability, cost or accessibility, for problems in basic biomedical, pre-clinical or clinical research, clinical care delivery, or accessibility. Clinical trials are optional.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up